Synopsis
0
CEP/COS
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
39
PharmaCompass offers a list of Citicoline Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Citicoline Sodium manufacturer or Citicoline Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Citicoline Sodium manufacturer or Citicoline Sodium supplier.
A cdp-choline, sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of cdp-choline, sodium, including repackagers and relabelers. The FDA regulates cdp-choline, sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. cdp-choline, sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of cdp-choline, sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A cdp-choline, sodium supplier is an individual or a company that provides cdp-choline, sodium active pharmaceutical ingredient (API) or cdp-choline, sodium finished formulations upon request. The cdp-choline, sodium suppliers may include cdp-choline, sodium API manufacturers, exporters, distributors and traders.
click here to find a list of cdp-choline, sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A cdp-choline, sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of cdp-choline, sodium active pharmaceutical ingredient (API) in detail. Different forms of cdp-choline, sodium DMFs exist exist since differing nations have different regulations, such as cdp-choline, sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A cdp-choline, sodium DMF submitted to regulatory agencies in the US is known as a USDMF. cdp-choline, sodium USDMF includes data on cdp-choline, sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The cdp-choline, sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of cdp-choline, sodium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The cdp-choline, sodium Drug Master File in Japan (cdp-choline, sodium JDMF) empowers cdp-choline, sodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the cdp-choline, sodium JDMF during the approval evaluation for pharmaceutical products. At the time of cdp-choline, sodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of cdp-choline, sodium suppliers with JDMF on PharmaCompass.
A cdp-choline, sodium written confirmation (cdp-choline, sodium WC) is an official document issued by a regulatory agency to a cdp-choline, sodium manufacturer, verifying that the manufacturing facility of a cdp-choline, sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting cdp-choline, sodium APIs or cdp-choline, sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a cdp-choline, sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of cdp-choline, sodium suppliers with Written Confirmation (WC) on PharmaCompass.
cdp-choline, sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of cdp-choline, sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right cdp-choline, sodium GMP manufacturer or cdp-choline, sodium GMP API supplier for your needs.
A cdp-choline, sodium CoA (Certificate of Analysis) is a formal document that attests to cdp-choline, sodium's compliance with cdp-choline, sodium specifications and serves as a tool for batch-level quality control.
cdp-choline, sodium CoA mostly includes findings from lab analyses of a specific batch. For each cdp-choline, sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
cdp-choline, sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (cdp-choline, sodium EP), cdp-choline, sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (cdp-choline, sodium USP).
